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OBJECTIVES This study investigated the role of angiotensin receptor subtype 1 (AT1) and angiotensin
receptor subtype 2 (AT2) in the regulation of Na
1-H1 exchanger (NHE) and Na1-HCO3
2
symporter (NBC) in the infarcted myocardium.
BACKGROUND The cardiac renin-angiotensin system is activated after myocardial infarction (MI), and both
angiotensin AT1 and AT2 receptors are upregulated in the myocardium.
METHODS Na1-H1 exchanger isoform-1 and NBC-1 gene expression were determined by reverse
transcription polymerase chain reaction and Northern blot analysis; protein levels by Western
blot analysis; and activity by measurement of H1 transport in left ventricular (LV) free wall,
interventricular septum (IS) and right ventricle (RV) after induction of MI. Rats were treated
with placebo, the angiotensin-converting enzyme inhibitor ramipril (1 mg/kg/day), the AT1
receptor antagonist valsartan (10 mg/kg/day) or the AT2 receptor antagonist PD 123319
(30 mg/kg/day). Treatment was started seven days before surgery.
RESULTS Na1-H1 exchanger isoform-1 and NBC-1 messenger RNA (mRNA) expression and protein
levels were increased twofold in the LV free wall after MI, whereas no changes were observed
in the IS and RV. Na1-dependent H1 flux was increased in the LV free wall. Ramipril
inhibited mRNA and protein upregulation of both transporters. Valsartan inhibited the
upregulation of NHE-1 mRNA and protein but had no effect on NBC-1 mRNA expression
and translation. In contrast, PD 123319 abolished the upregulation of NBC-1 mRNA and
protein but had no effect on NHE-1 upregulation. Ramipril and valsartan prevented post-MI
increase in NHE-1 activity, whereas ramipril and PD 123319 decreased NBC-1 activity.
CONCLUSIONS Angiotensin II via its AT1 and AT2 receptors differentially controls transcriptional and
translational regulation as well as the activity of NHE-1 and NBC-1 in the ischemic
myocardium and contributes to the control of pH regulation in cardiac tissue. (J Am Coll
Cardiol 2001;37:2154–65) © 2001 by the American College of Cardiology
Control of intracellular pH (pHi) is important in all tissues
because the accumulation of metabolic acid and other
perturbations of pHi can have profound effects on cellular
homeostasis. A number of pH regulatory proteins exist on
the plasma membrane to remove excess acid or its equiva-
lent. Among them are the Na1-H1 exchanger (NHE) and
the Na1-HCO3
2 symporter (NBC), which, when acti-
vated, induce an intracellular alkalinization (1,2). In the
mammalian myocardium, pHi regulation is of special im-
portance to the functioning heart because acidosis depresses
the contractility in cardiac myocytes by affecting virtually
every step in the excitation-contraction coupling (3). On
the other hand, pHi regulatory proteins, especially the
isoform-1 of NHE, have also been implicated in the
pathogenesis of tissue injury, arrhythmias during ischemia,
reperfusion and cell necrosis (4,5).
It has been recently recognized that these pHi-regulating
proteins can be acutely activated by angiotensin II (Ang II),
endothelin and beta-adrenergic agonists (6–8). Angiotensin
II has been shown to increase the activity of the two
Na1-dependent H1-extruding mechanisms, the NHE-1
(9) and Na1-HCO3
2 symporter isoform-1 (NBC-1) (6), in
cardiac muscle. However, it is not clear whether changes in
NHE-1 and NBC-1 expression and activity occur in the
clinical setting of ischemic heart disease, particularly after
myocardial infarction (MI).
Increasing evidence suggests that the renin-angiotensin
system is activated after acute MI. It has been demonstrated
that messenger RNA (mRNA) and protein levels for an-
giotensinogen (10), angiotensin-converting enzyme (ACE)
(11) and angiotensin receptors (12,13) are increased in rat
hearts after MI, and Ang II is considered to have a profound
effect on ventricular remodeling after MI (14).
The angiotensin receptors include at least two different
subtypes: the angiotensin receptor subtype 1 (AT1) is the
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predominant receptor in the adult rat heart and is consid-
ered to be the major mediator of the Ang II-induced effects
in the cardiovascular system (15). In contrast, angiotensin
receptor subtype 2 (AT2) activation has been reported to
inhibit cell proliferation (16); to induce differentiation (17),
apoptosis (18) and regeneration (19); and to be involved in
the control of voltage-sensitive ion currents (20).
This study was undertaken to investigate the influence of
angiotensin AT1 and AT2 receptors on pHi-regulating
systems in the rat myocardium at different time points after
MI. The NHE-1 complementary DNA (cDNA) (21) and
the NBC-1 cDNA (22) have been cloned from rat myocar-
dium, providing us with the possibility of investigating the
expression of these genes after MI. The antibodies to
cardiac NHE-1 (23) and recently generated antibodies to
NBC-1 (24) further enabled us to determine protein levels
of both transporters in the heart. To investigate whether
transcriptional and translational alterations of NHE-1 and
NBC-1 after MI contribute to the control of myocardial
pHi, we separately measured the H
1 efflux through both
transporters in tissue samples from infarcted rat hearts. We
then examined the effects of chronic pre- and post-MI
treatment with an ACE inhibitor, an AT1 receptor antag-
onist or an AT2 receptor antagonist on NHE-1 and NBC-1
mRNA expression, protein levels and transporter activity in
the rat myocardium.
Here we demonstrate for the first time an induction of
the cardiac NHE-1 and NBC-1 gene and protein expres-
sion as well as an increase in transporter activity after MI in
vivo, and we also demonstrate a differential role of angio-
tensin AT1 and AT2 receptor subtypes in transcriptional,
translational and functional regulation of these cardiac
transporters.
METHODS
Animals and study design. Male normotensive Wistar rats
(250 g, Charles River Viga, Sulzfeld, Germany) were used
in all experiments. Animals were housed individually at a
controlled temperature and humidity under a 12-h light/
dark cycle. The study was performed in accordance with the
German law on animal protection as released in its new
version in 1993.
Animals were randomly divided into five groups: 1) sham
operation without treatment, 2) MI subjected to placebo
treatment (0.9% saline), 3) MI subjected to ramipril treat-
ment (1 mg/kg/day), 4) MI subjected to valsartan treatment
(10 mg/kg/day), and 5) MI subjected to PD 123319
treatment (30 mg/kg/day). For surgical procedures, rats
were anesthetized by injection of methohexital-Na1
(10 mg/kg intravenous) and artificially ventilated (70 ven-
tilations/min, 200 mm H2O, 2.5 ml/ventilation) to perform
a left thoracotomy. Myocardial infarction was induced by
permanent ligation of the left coronary artery. The AT1 and
AT2 receptor antagonists valsartan and PD 123319, respec-
tively, were given via osmotic minipumps, and the ACE
inhibitor ramipril was given via gastric lavage. Drug dosages
for ramipril (25), valsartan (26) and PD 123319 (27) were
adjusted to the individual body weight of each rat to ensure
effective receptor or enzyme blockade, respectively. Valsar-
tan and PD 123319 were dissolved in 1 N NaOH and
buffered with HCl (pH 7.4) before filling into minipumps.
Ramipril was dissolved in water. Treatment began one week
before induction of MI in all groups and continued until
sacrifice. On days 1 and 7 after induction of MI, the rats
were decapitated, and the hearts were rapidly excised. The
left ventricle (LV) was separated from the atria and the right
ventricle (RV) and then divided into the interventricular
septum (IS) and the LV free wall by an incision along the
line where the RV was cut off from the LV. The LV free
wall consisted of scar tissue and area at risk. Tissue samples
were rapidly frozen in liquid nitrogen and stored at 280°C
until use. The number of animals was six per group.
RNA extraction, reverse transcription polymerase chain
reaction (RT-PCR) and Northern blot analysis. For
measurement of gene expression, total RNA was isolated
from the fresh-frozen tissue using a single-step isolation
method described by Chomczynski and Sacchi (28), and
RNA concentration was determined by densitometric mea-
surement of ultraviolet absorption at 260 nm. Poly(A1)-
RNA was isolated from total RNA by using Oligotex
mRNA Mini Kit (QIAGEN, Hilden, Germany). Trizol
solution, molecular size standards, Super Script Preampli-
fication Systems and Taq polymerase were purchased from
Gibco BRL (Eggenstein, Germany). The reverse transcrip-
tion of total RNA (5 mg) was performed with oligo (dT)
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primers using Prime-It II Random Primer Kit reagents
(Strategene, Heidelberg, Germany). The primer sequences
(Pharmacia Biotech, Cambridge, United Kingdom) used
in RT-PCR for amplification of cardiac NHE-1 were
59-AGAAAAAGCAAGAAACAAAGCG-39 (sense)
and 59-GTGGTAGAAGGAAATGAGCTG-39 (anti-
sense), resulting in a product size of 209 base pair (bp)
and, for amplification of cardiac NBC-1, were 59-
CAAGAAGATGATCAAGCTGGC-39 (sense) and 59-
AGGACATGAGTGTGATGTCAG-39 (antisense) (prod-
uct size 287 bp; from gene bank accession no AF001958) (29).
The primer sequences for the house keeping gene
glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
were 59-GAATTCCATTGACCTCAACTACATGG-39
(sense) and 59-TTGCTGCAGTCTTACTCCTT-
GGAGGCCAT-39 (antisense) (product size 916 bp). Exact
polymerase chain reaction (PCR) protocols for the various
amplification reactions are given in Table 1. At the end of
amplification reactions, PCR products were incubated at
72°C for 5 min for a final extension. Aliquots of each sample
were subjected to electrophoresis on a 1.2% agarose gel and
stained with ethidium bromide. The identity of PCR
products was verified by sequence analysis (data not shown).
To ensure a high reproducibility, each sample was subjected
to three independent PCR reactions for NHE-1, NBC-1
and GAPDH.
For Northern blot analysis, 8 mg of Poly(A1)-RNA from
each tissue sample was denatured with formaldehyde, frac-
tionated by electrophoresis through 1.2% agarose gel and
transferred and fixated (2 h at 80°C) to a nylon membrane
(Hybond-N Membrane, Amersham, Braunschweig, Ger-
many). Hybridizations were carried out in a Rapid-Hyb
solution (Amersham, Braunschweig, Germany) using 32P-
labelled probes. Membranes were washed using high strin-
gency conditions: once for 30 min at 22°C in 13 SSC/0.1%
SDS and once for 60 min at 60°C in 0.1 SSC/0.1% SDS.
The blots were then examined by autoradiography. Expo-
sure times were 20 h for Northern blots probed with
NHE-1, 24 h for NBC-1 and 4 h for GAPDH. The
fragment used for labeling of rat NHE-1 message was 233
to 634 bp of the rat NHE-1 cDNA sequence corresponding
with the coding region. The fragment for probing the
NBC-1 message was 633 to 822 bp and for GAPDH
message was 568 to 989 bp. The cDNA fragments were
radiolabeled with [a-32P]dCTP (1 3 109 cpm/mg of DNA,
Amersham, Braunschweig, Germany) using the random
primer procedure (Strategene).
For the quantification of mRNA, bands were scanned
and analyzed using the public domain National Institutes of
Health image program. For all RNA samples, the density of
the bands were divided by that of the GAPDH mRNA
band.
Protein extraction and Western blot analysis. In the
second set of the experiments, protein levels of cardiac
NHE-1 and NBC-1 were determined in additional sham-
operated and placebo-, ramipril-, valsartan- and PD
123319-treated infarcted groups. At day 1 and day 7 after
MI, the three tissue samples (RV, IS, LV free wall) of each
animal were homogenized in 5 ml of ice cold lysis buffer
containing 50 mM Tris-HCl (pH 7.4), 0.5M EDTA,
150 mM NaCl, 0.1% Triton-100, freshly added proteinase
inhibitor (100 mg/ml PMSF, 1 mg/ml Trasylol) followed by
centrifugation at 14,000 rpm at 4°C for 1 min. The
supernatant was collected, and aliquots were mixed with
loading buffer (1M Tris-HCl [pH 6.8], 1% SDS, 30%
glycerol, 0.8M DTT, 2% bromphenolblue) and solubilized
for 10 min at 95°C and then centrifuged 30 min at 14,000
rpm at 4°C. Protein concentration was determined by the
method of Bradford (30) using bovine serum albumin as a
standard. All preparations were carried out at 4°C.
For Western blotting, 100 mg of total protein per lane
was separated by a 10% SDS-PAGE gel. Proteins were
transferred onto Hybond-C Super transfer membrane (Am-
ersham, Life Science, Germany). The membrane was
washed three times for 20 min in TTBS (0.1% Tween 20,
100 mM Tris-HCL, 150 mM NaCl, pH 7.5), blocked for
1 h in 5% nonfat milk/TTBS and incubated with primary
rabbit polyclonal antibodies (Alpha Diagnostic, Bio Trend
Chemicalien GmbH, Germany) for the cardiac NHE-1
(1:1,000) or NBC-1 (1:300) (31). In control experiments,
Western blots were performed with rat kidney homogenates
to ensure that the size of the detected bands for cardiac
NBC-1 corresponded to those from the kidney. After three
washes in TTBS, the membrane was incubated with a
1:1,000 dilution of the anti-rabbit horseradish-peroxidase
coupled secondary antibody (Amersham, Braunschweig,
Germany) for 30 min at room temperature. After extensive
washes in TTBS, NHE-1 and NBC-1 were detected using
ECL-reagents (Amersham, Braunschweig, Germany) and
exposed to ECL-film according to the manufacturer’s in-
structions. Quantification of Western blots was performed
Table 1. PCR Conditions for Amplification of NHE-1, NBC-1 and GAPDH
Product
PCR
Buffer/ml
MgCl2
(1.5 mM/ml)
dNTPs
(0.2 mM/ml)
Primers
(20 mM/ml)
Taq-Polymerase
(2.5 U/ml)
Annealing
Temperat.
(°C/min)
Number
of PCR
Cycles
NHE-1 5.0 1.5 2.0 1.0 0.25 57 26
NBC-1 5.0 1.5 2.0 1.0 0.25 56 27
GAPDH 5.0 3.0 1.0 1.0 0.25 60 23
GAPDH 5 glyceraldehyde-3-phosphate dehydrogenase; NBC-1 5 Na1-HCO3
2 symporter isoform-1; NHE-1 5 Na1-H1 exchanger isoform-1; PCR 5 polymerase chain
reaction.
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on a computer using the National Institutes of Health
image analysis system (Scion Corporation, Frederick, Mary-
land).
Preparation of heart tissue samples and pHi measure-
ment. In a third protocol, sham-operated and infarcted
animals treated either with placebo, ramipril, valsartan or
PD 123319 were decapitated seven days after MI; the hearts
were quickly excised and fixated in a preparation dish
containing ice cold physiological saline solution (PSS)
(119 mM NaCl, 4.7 mM KCl, 1.18 mM KH2PO4,
1.17 mM MgSO4, 25 mM NaHCO3, 2.5 mM CaCl2,
0.026 mM EDTA, 5 mM HEPES, 5.5 mM D-glucose, pH
7.45 to 7.50 when gassed with 5% CO2/95% O2). Under a
stereo microscope, the LV was then opened by an incision
at the septum to carefully dissect a fresh heart tissue sample
from the fringe of the inner endocardial LV free wall,
representing a myocardial muscle probe from the ischemic
region of the infarcted rat heart. Tissue samples were
mounted in a tissue bath placed on the stage of an inverted
microscope equipped with a photomultiplier, gassed with
5% CO2/95% O2 and heated to 37°C. The preparations
were loaded for 60 min with 5 mM of the pH-sensitive
membrane-permeable acetoxymethylester of the fluores-
cence dye 29,79-bis-(2-carboxyethyl)-5 (and -6)-
carboxyfluorescein (BCECF-AM), as described previously
(32). The tissue samples were excited alternately with light
at 440 and 495 nm provided by a 75-W xenon lamp, which
fed into a monochromator (PTI Deltascan). The emission
from the preparation passed through a bandpass filter (515
to 560 nm) and was, via the photomultiplier, fed into the
computer where the ratio of emission at the two different
excitation wavelengths was calculated after subtraction of
background fluorescence. A ratio measurement was ob-
tained every 1 s in these experiments. At the end of the
experiments, the ratio was calibrated in terms of pHi with
4 mg/l nigericin in a 125 mM KCl solution (NaCl substi-
tuted with KCl) (33).
In order to determine the cellular buffering power (bi),
the ammonia washout technique was used (34). In brief, an
initial alkalinization of the myocardial tissue samples was
induced by applying 30 mM NH4Cl for 8 min in 1-mM
amiloride containing Na1-free PSS (Na1 substituted with
N-methyl-D-glucamine) followed by stepwise (20 mM,
5 mM and 0 mM NH4Cl) washout of NH4Cl. The
resultant changes in pHi were used to estimate bi as follows:
bi (mM) 5
D[NH4
1]i
DpHi
,
where
@NH4
1#i 5
([H1]i 3 [NH4
1]0)
[H1]0
and
@NH4
1#0 5 @NH3#0 3 10pKa-pHo (pKa NH3 5 9,27).
bi values were plotted as a function of pHi and fitted to an
exponential.
The H1 efflux (JH) was calculated from the equation
JH 5 bi(dpHi/dt), where bi is the buffering power and
dpHi/dt is the rate of pHi recovery. The data points were
plotted as a function of pHi and fitted to an exponential.
The JH was calculated at pHi of 7.05 by multiplying bi with
the appropriate dpHi/dt. To estimate H
1 efflux through the
NBC-1, JH via the NHE-1 measured in HCO3
2-free
solution (NaHCO3
2 substituted with NaCl and the solu-
tion gassed with 100% O2) was subtracted from total JH
measured in PSS.
Statistics. Computer-assisted programs based on square
fitting methods served to analyze RT-PCR standard curves.
Statistical evaluation was determined using one-way analysis
of variance with repeated measurements. Means shown to
be different between individual groups were compared using
the post-hoc unpaired Student t test or the Bonferroni test.
A p value #0.05 was considered to be significant. Results
are expressed as means 6 SEM. Further details of statistical
analysis are given in the legends to the figures.
RESULTS
Effects of ACE inhibitor and AT receptor antagonists on
cardiac NHE-1 and NBC-1 mRNA abundance after MI.
Expression studies of cardiac NHE-1 and NBC-1 mRNA
resulted in single bands of the predicted size for NHE-1 of
4.8 kb, for NBC-1 of 7.5 kb and for the house keeping gene
GAPDH of 0.9 kb, as previously seen in other organs
(21,29). We found identical expression patterns both by
RT-PCR and Northern blot analysis. The GAPDH signals
used as an internal control did not change in the rat
myocardium during the early phase after MI (34). The levels
of cardiac NHE-1 and NBC-1 mRNA quantified by
densitometric scanning were related to the GAPDH signals
and expressed by folds of increase from those of sham-
operated rats. In the LV free wall, NHE-1 and NBC-1
mRNA abundance was significantly increased after MI,
compared with sham operation. The message of NHE-1
was increased twofold on day 1, was elevated more than
twofold seven days after MI and decreased to baseline values
14 days after MI, as shown by RT-PCR and Northern blot
analysis (Fig. 1, A and B). Similarly, the message of NBC-1
was elevated on day 1, further increased on day 7 and
decreased 14 days after MI (Fig. 2, A and B). Because the
RT-PCR reaction was specific for NBC-1, these results
demonstrate for the first time an MI-induced upregulation
of this transporter in the rat myocardium. In sham-operated
rats, NHE-1 and NBC-1 mRNA expression were un-
changed on day 1 and day 7 after surgery compared with
that of healthy rats (data not shown). In the IS and the RV,
NHE-1 and NBC-1 expression were unchanged through-
out the seven day post-MI period when compared with that
of sham-operated rats (data not shown).
Pretreatment with the ACE inhibitor ramipril prevented
the increase in cardiac NHE-1 mRNA expression on day 1
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and markedly attenuated the increase in NHE-1 expression
on day 7 (Fig. 3A) and prevented the upregulation of
NBC-1 mRNA expression on days 1 and 7 (Fig. 3B) in the
LV free wall of the infarcted rat myocardium. These results
indicate that Ang II is involved in the upregulation of
NHE-1 and NBC-1 in the ischemic region of the infarcted
rat heart. To determine which angiotensin receptor subtype
mediated the upregulation of NHE-1 and NBC-1 mRNA
expression after MI, animals were pretreated one week
before and up to sacrifice after MI with the selective AT1
and AT2 receptor antagonists valsartan and PD 123319,
respectively. The results illustrated in Figure 3A show that
the increase in mRNA expression of NHE-1 was com-
pletely prevented on day 1 and markedly inhibited on day 7
by the AT1 receptor antagonist valsartan but not by the AT2
receptor antagonist PD 123319. In contrast, PD 123319
totally prevented the NBC-1 mRNA upregulation at both
time points, whereas valsartan did not affect the NBC-1
mRNA expression (Fig. 3B). These findings demonstrate
that the increase in NHE-1 expression after MI is mediated
to a large extent by the AT1 receptor, whereas the AT2
receptor controls NBC-1 upregulation.
Effects of ACE inhibitor and AT receptor antagonists on
NHE-1 and NBC-1 protein levels. Protein levels for
cardiac NHE-1 and NBC-1 were determined in the RV, IS
and LV free wall of sham-operated and infarcted animals
with placebo, ramipril, valsartan or PD 123319 treatment
one day and seven days after MI using Western blot
analysis. The density of the digitized signals was quantified
as a percentage of the signal density of sham-operated rats,
which was set to 100%, respectively. In the rat myocardium,
we detected a single band of approximately 110 kDa for
cardiac NHE-1. For the NBC-1, we saw a strong band at
approximately 115 to 120 kDa and a weaker band at
approximately 135 kDa in the rat myocardium. With the
antibody used, we had previously seen in rat kidney a band
at approximately 135 kDa, which was reduced to approxi-
mately 116 kDa after deglycosylation (31). Therefore, it is
likely that the two bands represent the glycosylated and the
nonglycosylated NBC-1. As demonstrated for NHE-1
mRNA expression, the protein levels of this transporter
were increased in the LV free wall of placebo-treated
infarcted animals one day after MI and reached maximum
values seven days after MI compared with those of sham-
Figure 1. (A) Representative experiments showing upregulation of Na1-H1 exchanger isoform-1 (NHE-1) messenger RNA (mRNA) in the myocardium
of sham-operated and placebo-treated animals with myocardial infarction (MI) one day and seven days after MI. Total RNA obtained from the left
ventricular (LV) free wall was amplified by reverse transcription polymerase chain reaction (upper line) and analyzed by Northern blot (lower line). (B)
Relative changes in mRNA expression were determined by densitometric analysis and normalized to glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
signals. *p , 0.05 compared with sham operation. Data represent mean 6 SEM, n 5 6.
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operated animals (Fig. 4A). Fourteen days after MI, protein
levels of NHE-1 showed lower values compared with seven
days after MI values (data not shown). The protein amount
of NHE-1 was not significantly different in the RV and IS
of infarcted and sham-operated rat hearts at both time
points measured (data not shown). Chronic treatment of
infarcted animals with the ACE inhibitor ramipril and the
AT1 receptor antagonist valsartan completely prevented
(one day after MI) and significantly reduced (seven days
after MI) NHE-1 protein upregulation in the LV free wall
compared with that of placebo-treated MI animals. In
contrast, the AT2 receptor antagonist PD 123319 had no
effect on protein upregulation of cardiac NHE-1 at both
time points (Fig. 4A). No significant differences in NHE-1
protein values in the RV and IS were observed between the
four treated MI groups at any time point measured (data not
shown).
One day after MI, protein levels for NBC-1 were
increased in the LV free wall of placebo-treated infarcted
animals and reached maximum levels on day 7 after MI
(twofold) compared with those of sham-operated animals
(Fig. 4B). Protein levels of this transporter were reduced 14
days after MI compared with seven days after MI (data not
shown). Similarly to mRNA expression, the MI-induced
increase in NBC-1 protein levels in the LV free wall was
totally prevented by chronic treatment with the ACE
inhibitor ramipril and the AT2 receptor antagonist PD
123319 but not influenced by the AT1 receptor antagonist
valsartan compared with placebo-treated infarcted animals
(Fig. 4B). The NBC-1 protein concentrations in the RV
and IS of sham-operated animals did not differ significantly
from those of infarcted animals at both time points mea-
sured and was unaffected by chronic treatment with
ramipril, valsartan or PD 123319 (data not shown).
Effects of ACE inhibitor and AT receptor antagonists on
Na1-dependent H1 transport after infarct. To investi-
gate the contribution of the membrane transporters NHE-1
and NBC-1 to the recovery from an intracellular acid load in
the ischemic myocardium, the activity of these transporters
was assessed by measuring Na1-dependent H1 efflux (JH)
in the presence and absence of bicarbonate. The Na1-
dependent JH in the absence of bicarbonate (NHE activity)
was increased in the LV free wall of placebo-treated
infarcted animals (threefold) on day 7 after MI compared
Figure 2. (A) Representative experiments showing upregulation of Na1-HCO3
2 symporter isoform-1 (NBC-1) messenger RNA (mRNA) in the
myocardium of sham-operated and placebo-treated animals with myocardial infarction (MI) one day and seven days after MI. Total RNA obtained from
the left ventricular (LV) free wall was amplified by reverse transcription polymerase chain reaction (upper line) and analyzed by Northern blot (lower line).
(B) Relative changes in mRNA expression were determined by densitometric analysis and normalized to glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) signals. *p , 0.05 compared with sham operation. Data represent mean 6 SEM, n 5 6.
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with sham-operated animals. Chronic treatment with the
ACE inhibitor ramipril and the AT1 receptor antagonist
valsartan prevented the MI-induced increase in the activity
of this transport, whereas the AT2 receptor antagonist PD
123319 did not significantly affect the H1 efflux through
NHE-1 (Fig. 5 and 6A). At the same time point, the Na1-
and bicarbonate-dependent JH (NBC activity) was also
increased in placebo-treated infarcted animals (fourfold)
when compared with sham-operated animals. Treatment
with ramipril and PD 123319 prevented the increase in the
activity of NBC-1 in the LV free wall. In contrast, valsartan
had no effect on the activity of NBC-1 in the LV free wall
of the infarcted rat heart (Fig. 5 and 6B).
DISCUSSION
In this study, we demonstrate for the first time an increase
in steady-state NHE-1 and NBC-1 mRNA expression and
protein levels as well as a rise in the Na1-dependent JH
consistent with an increase of NHE-1 and NBC-1 activity
in the ischemic region of the infarcted rat heart. Further-
more, our data point to a differential role of angiotensin
AT1 and AT2 receptors in the regulation of NHE-1 and
NBC-1 gene expression, protein translation and transport
activity in the ischemic myocardium.
Contribution of NHE-1 and NBC-1 in pHi regulation of
the ischemic myocardium. Our results show that MI
induces an upregulation of NHE-1 and NBC-1 mRNA and
protein in the LV free wall but not in the IS and RV during
the early phase after MI. The exact mechanism underlying
these events has yet to be established. It is possible that
there is an increase in transcriptional and translational
regulation, a decrease in mRNA and protein degradation or
Figure 3. Effects of chronic treatment with the angiotensin-converting
enzyme inhibitor ramipril (1 mg/kg/day), the AT1 receptor antagonist
valsartan (10 mg/kg/day) and the AT2 receptor antagonist PD 123319
(30 mg/kg/day) on messenger RNA (mRNA) expression of Na1-H1
exchanger isoform-1 (NHE-1) (A) and Na1-HCO3
2 symporter isoform-1
(NBC-1) (B) in the left ventricular free wall one day and seven days after
myocardial infarction (MI) compared with sham-operated and placebo-
treated animals with MI. *p , 0.05 compared with sham operation; #p ,
0.05 compared with placebo MI. Data represent mean 6 SEM, n 5 6.
Figure 4. Effects of chronic treatment with the angiotensin-converter
enzyme inhibitor ramipril (1 mg/kg/day), the AT1 receptor antagonist
valsartan (10 mg/kg/day) and the AT2 receptor antagonist PD 123319
(30 mg/kg/day) on protein levels of Na1-H1 exchanger isoform-1
(NHE-1) (A) and Na1-HCO3
2 symporter isoform-1 (NBC-1) (B) in the
left ventricular free wall one day and seven days after myocardial infarction
(MI) compared with sham-operated and placebo-treated animals with MI.
*p , 0.05 compared with sham operation; #p , 0.05 compared with
placebo MI. Data represent mean 6 SEM, n 5 6. PD 5 PD 123319; Pl 5
placebo; Ra 5 ramipril; Sh 5 sham-operated; Va 5 valsartan.
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a combination of both. In these experiments, permanent
ligation of the left coronary artery results in an ischemia of
the LV free wall known to produce an intracellular acidosis
within this region, whereas the IS and the RV are not
ischemic (35). Acidosis can act as a specific mechanism to
increase gene expression and protein translation or to
decrease mRNA and protein degradation of both NHE-1
and NBC-1 (36,37). Additionally, translational and tran-
scriptional upregulation of the cardiac membrane transport-
ers was accompanied by an increase in the activity of
Na1-dependent H1 flux consistent with a functional im-
portance of the transporter upregulation.
The primary function of cardiac NHE-1 is to regulate
intracellular pH (pHi) by extruding H
1 in exchange for
Na1 in a one-to-one fashion. Thus, NHE-1 also partici-
pates in the regulation of intracellular Na1 (Na1i), as
demonstrated by Frelin et al. (38) using rat and chicken
heart cells. In that study, amiloride and its analogues
prevented Na1 influx after H1 gradient-induced activation
of NHE-1. Activation of NHE-1 was shown to account for
as much as 50% of the basal permeability of the membrane
to Na1 (38). In cardiac cells, which have been shown to
possess both Na1-H1 and Na1-Ca21 exchanger (NCE)
systems, changes in pHi result in an alteration of the
intracellular Ca21-concentration (Ca21i) because of the
close linkage of these two exchanger proteins via cytosolic
Na1 (38,39). As a result of cardiac NHE-1 activation after
intracellular acidosis, accumulated Na1 can be exchanged
for Ca21 via cardiac NCE at a 3:1 ratio leading to an
increase in Ca21i (Fig. 7). The idea that stimulation of
NHE-1 induces an intracellular Ca21-overload via NCE
has been addressed in a number of investigations (40,41). In
our experiments, it is possible that the activation of NHE-1
in the rat myocardium after MI, although important for the
restoration of normal pHi, might result in a paradoxical
aggravation of tissue injury because the increase in Na1i due
to activation of NHE-1 would lead to an enhanced Ca21i
via NCE, which has been shown to be associated with cell
death and arrhythmias (4,5). An enhanced expression of
cardiac NHE-1 after MI could thus lead to an increased
incidence of tissue injury, cell necrosis and arrhythmias. Con-
versely, inhibitors of NHE-1 have been found to effectively
protect the myocardium from damage after MI (42).
The NBC activity has been shown to have a stoechiom-
etry of 3 HCO3
2 to 1 Na1 in the kidney. In the heart, an
electroneutral NBC activity has been described (43) in
cardiac myocytes from sheep but an HCO3
2:Na1 ratio of
1.63 has been suggested based on experiments in rat cardiac
myocytes (44). In this study, we specifically assessed
NBC-1, which is an electrogenic NBC with a stoechiom-
etry different from 1:1. Our functional assays did not
address the question of which NBC isoform was involved.
However, the good correlation between NBC-1 regulatory
and functional data is consistent with the interpretation that
the HCO3
2- and Na1-dependent net H1 influx to a large
extent reflects the activity of NBC-1 (3:1 ratio). This
transporter has been shown to be colocalized directly with
the Na1-K1 pump within the plasma membrane (45),
suggesting that the NBC-induced Na1 accumulation could
be removed immediately from the cytosol via the coupled
Na1-K1 pump in exchange to K1 (3:2 ratio). The Na1-K1
pump mediated Na1 efflux causes a hyperpolarization of the
cell membrane that might protect the myocardium against
arrhythmias (Fig. 7). Thus, an enhanced expression, trans-
lation and activity of the electrogenic NBC in the ischemic
myocardium could play a cardioprotective role.
Figure 5. Representative original traces showing recovery from intracellular acidosis after stepwise washout of 30 mM NH4Cl of endocardial tissue
preparations from infarcted rat hearts. Effects of chronic treatment with the angiotensin-converting enzyme inhibitor ramipril, the AT1 receptor antagonist
valsartan and the AT2 receptor antagonist PD 123319 on puffering power (bi) and proton efflux (JH) seven days after myocardial infarction (MI) compared
with sham-operated and placebo-treated animals with MI. ami 5 amiloride; PSS 5 physiological saline solution.
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Effects of ACE inhibitor and AT receptor antagonists on
pHi regulation in the ischemic myocardium. A central
aim of our study was to investigate the differential role of
angiotensin AT1 and AT2 receptor subtypes in the regula-
tion of NHE-1 and NBC-1 in the rat myocardium after
MI. The localization of angiotensinogen and renin within
cardiac myocytes and fibroblasts has been shown using in
situ hybridization and immunofluorescence techniques (46).
Additionally, an activation of the tissue-specific cardiac
ACE has been demonstrated in experimental heart failure
(11), supporting the view of the existence of an intracardiac
renin-angiotensin system. Angiotensin-converting enzyme
inhibition has been shown to have an influence on cardiac
remodeling and to prolong survival in patients with LV
dysfunction after MI (47,48). Ennis et al. (49) demonstrated
that the ACE inhibitor enalapril induced normalization of
pHi regulatory mechanisms in the hypertrophic myocar-
dium of spontaneously hypertensive rats, which exhibit
increased NHE-1 activity. This is in accordance with our
observation that the ACE inhibitor ramipril inhibited the
mRNA and protein upregulation of NHE-1 and NBC-1 as
well as the activation of the Na1-dependent JH.
Angiotensin II binds to at least two different types of
receptors, referred to as AT1 and AT2 (50), which both have
been shown to be expressed in the rat myocardium (51). It
has been demonstrated that AT1 and AT2 receptors are
significantly increased in the rat heart during the early phase
after MI (13,52). Our present data show that the Ang
II-induced stimulation of NHE-1 is mediated, at least in
part, via activation of the AT1 receptor, whereas AT2
receptor activation induced the stimulation of NBC-1.
These findings extend previous observations showing that
Ang II has an acute activating effect on NHE activity
(9,53,54) by demonstrating long-term upregulation of
NHE in vivo.
Angiotensin II has also been shown to acutely activate
NBC in neonatal myocytes, an effect that was ascribed to
the AT2 receptor (6). In this study, the upregulation of
NBC-1 at mRNA and protein level was abolished at both
time points after MI by the AT2 receptor antagonist PD
123319, indicating that this receptor is indeed crucial for the
enhanced expression and translation of cardiac NBC-1
under ischemic conditions. On the other hand, the fact that
the upregulation of NHE-1 was abolished by the AT1
receptor antagonist valsartan on day 1 after MI, whereas, on
day 7 after MI, this inhibition was not complete, suggests
that Ang II-independent mechanisms also contribute to the
regulation of NHE-1 at later time points after MI. For
instance, in rat ventricular myocytes, it has been demon-
strated that a1-adrenergic stimulation acutely causes an
alkalinization of pHi and an enhanced rate of NHE-
mediated recovery from an acid load (55). Endothelin (56)
and thrombin (57) have also been shown to activate the
cardiac NHE-1 of rat myocytes.
One of the important findings of this study is the
discrimination between the mechanism involved in the
expression of NHE-1 and NBC-1 by using an in vivo
animal model of MI. The possible clinical consequences of
this intriguing observation deserve comments. Many reports
suggest that the AT1 receptor subtype plays a major role in
cardiac pathophysiology, and the administration of AT1
receptor antagonists has been shown to reduce infarct size
(58) and LV loading (59) and to improve hemodynamics
and coronary angiogenesis (14) after MI. Consistent with
these and our present findings, Harada et al. (60) have
recently reported on reduced reperfusion arrhythmias in
AT1a receptor knockout mice. The role of cardiac AT2
receptors in the control of heart function remains to be
clarified. In isolated ischemic rat hearts and after MI, the
cardioprotective effect of AT1 receptor blockade may be
mediated, in part, by endogenously released Ang II via AT2
receptor stimulation (61). Since ACE inhibitors, in addition
to reducing NHE-1 expression, also reduce NBC-1 expres-
Figure 6. Effects of chronic treatment with the angiotensin-converting
enzyme inhibitor ramipril (1 mg/kg/day), the AT1 receptor antagonist
valsartan (10 mg/kg/day) and the AT2 receptor antagonist PD 123319
(30 mg/kg/day) on Na1-dependent HCO3
2-independent net H1 influx
(NHE activity; A) and Na1 and HCO3
2-dependent net H1 influx (NBC
activity; B) in endocardial tissue preparations seven days after myocardial
infarction compared with sham-operated and placebo-treated animals with
myocardial infarction. *p , 0.05 compared with sham operation; #p , 0.05
compared with placebo-treated myocardial infarction. Data represent
mean 6 SEM, n 5 10 to 12.
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sion, they prevent the selective AT2 receptor-mediated
effect of NBC-1 upregulation during ischemia. On the
other hand, since AT1 receptor antagonists block NHE-1
upregulation but stimulate NBC-1 activity via the AT2
receptor, they may have a potential clinical advantage in the
early phase therapy of MI (Fig. 7).
Conclusions. In summary, the results of this study dem-
onstrate that NHE-1 and NBC-1 mRNA and protein levels
are increased in the LV free wall but not in the IS and the
RV of rat hearts in the first week after MI. Additionally, MI
induces an increase in the Na1-dependent JH consistent
with an elevated activity of both transporters playing a role
for the recovery from intracellular acidosis. Chronic treat-
ment with an ACE inhibitor effectively reduced mRNA up-
regulation, protein upregulation and transport activity of
cardiac NHE-1 and NBC-1. Treatment with an AT1
receptor antagonist markedly reduced mRNA2, protein
upregulation and transport activity through NHE-1 but had
no effect on NBC-1 expression, whereas treatment with an
AT2 receptor antagonist significantly reduced the upregu-
lation of the NBC-1 mRNA2, protein and transport
activity but had no effect on NHE-1 upregulation. The
results suggest that the myocardial cell damage induced by
NHE-1 upregulation after MI can be prevented either by
ACE inhibition or AT1 receptor blockade. Additionally,
our findings suggest that AT1 receptor antagonists may shift
the recovery from ischemia-induced myocardial acidosis
from an NHE-1-mediated to a more NBC-1-mediated
mechanism of alkalinization by engaging the angiotensin
AT2 receptor.
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